Antipsychotic metabolic monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Weight, glucose or HbA1c, lipids and blood pressure
Olanzapine is associated with weight gain, dyslipidaemia and glucose dysregulation. Baseline and follow-up cardiometabolic monitoring is needed. The other tests are not routine safety checks for olanzapine therapy.
Reference: BNF; NICE CKS